[Effect of urokinase on the tumor blood flow studied by Xenon-133 method (author's transl)].
D000970:Antineoplastic Agents / Q000008:administration & dosage; D010450:Endopeptidases / Q000494:pharmacology*; D006801:Humans; D007269:Injections, Intra-Arterial; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000503:physiopathology*; D012039:Regional Blood Flow / Q000187:drug effects*; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000494:pharmacology*; D014980:Xenon Radioisotopes
D000970:Antineoplastic Agents; D014980:Xenon Radioisotopes; D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator